Gold Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79K Hold
100
﹤0.01% 179
2026
Q1
$3.67K Hold
100
﹤0.01% 181
2025
Q4
$5.09K Hold
100
﹤0.01% 182
2025
Q3
$5.55K Hold
100
﹤0.01% 181
2025
Q2
$6.98K Hold
100
﹤0.01% 172
2025
Q1
$6.94K Hold
100
﹤0.01% 178
2024
Q4
$8.6K Hold
100
﹤0.01% 170
2024
Q3
$11.9K Hold
100
0.01% 165
2024
Q2
$14.3K Hold
100
0.01% 165
2024
Q1
$12.8K Hold
100
0.01% 165
2023
Q4
$10.3K Buy
+100
New +$9.89K ﹤0.01% 168

Other funds holding NVO

Gold Investment Management's NVO Position: Q2 2026 in Review

Gold Investment Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 100 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

Gold Investment Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $14.3K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Gold Investment Management held 100 shares of Novo Nordisk worth $4.79K as of Q2 2026.
  • Gold Investment Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Gold Investment Management's portfolio in Q2 2026, its #179 holding.
  • Gold Investment Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Gold Investment Management's Novo Nordisk position peaked at $14.3K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Gold Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.